SBC / revenue moved 255 bp lower
SBC / revenue changed -255 basis points from the comparable as-filed period.
9.21%→6.66%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PTCT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed across a sign change
Net income changed -425.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$15.9M→-$51.7M2 prior comparisons
Total assets increased 21.3%
Total assets changed +21.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.6B→$3.2B4 prior comparisons
Working capital / assets moved 1174 bp higher
Working capital / assets changed +1174 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
43.18%→54.92%4 prior comparisons
Free-cash-flow margin moved 2524 bp higher
Free-cash-flow margin changed +2524 basis points from the comparable as-filed period.
-33.05%→-7.82%2 prior comparisons
R&D / revenue moved 1802 bp lower
R&D / revenue changed -1802 basis points from the comparable as-filed period.
47.47%→29.44%2 prior comparisons
Operating cash-flow margin moved 2435 bp higher
Operating cash-flow margin changed +2435 basis points from the comparable as-filed period.
-31.42%→-7.07%2 prior comparisons
Stock-based compensation increased 22.7%
Stock-based compensation changed +22.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$19.4M→$23.8M2 prior comparisons
Current liabilities decreased 10.4%
Current liabilities changed -10.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$866.2M→$776.1M4 prior comparisons
Capex / revenue moved 89 bp lower
Capex / revenue changed -89 basis points from the comparable as-filed period.
1.63%→0.74%2 prior comparisons
Research & development increased 5.2%
Research & development changed +5.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$100.2M→$105.4M2 prior comparisons
Capital expenditure decreased 22.9%
Capital expenditure changed -22.9% from the comparable as-filed period.
$3.4M→$2.7M2 prior comparisons
Shares outstanding increased 4.1%
Shares outstanding changed +4.1% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
80,288,305→83,544,2847 prior comparisons
Selling, general & administrative decreased 4.7%
Selling, general & administrative changed -4.7% from the comparable as-filed period.
$84.0M→$80.1M2 prior comparisons
Current liabilities increased 22.8%
Current liabilities changed +22.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$627.8M→$771.1M4 prior comparisons
Current assets increased 15.2%
Current assets changed +15.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.3B→$2.6B4 prior comparisons
Shares outstanding increased 5.1%
Shares outstanding changed +5.1% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
79,438,094→83,460,8027 prior comparisons
Stock-based compensation increased 25.6%
Stock-based compensation changed +25.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$18.5M→$23.3M2 prior comparisons
Net income changed across a sign change
Net income changed +228.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$64.8M→$83.5M2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +312.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$59.7M→$126.9M3 prior comparisons
R&D / revenue moved 3566 bp lower
R&D / revenue changed -3566 basis points from the comparable as-filed period.
63.17%→27.50%2 prior comparisons
Working capital / assets moved 565 bp lower
Working capital / assets changed -565 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
62.45%→56.80%4 prior comparisons
Operating cash-flow margin moved 6842 bp higher
Operating cash-flow margin changed +6842 basis points from the comparable as-filed period.
-32.61%→35.81%2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +321.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$58.3M→$129.1M3 prior comparisons
Free-cash-flow margin moved 6855 bp higher
Free-cash-flow margin changed +6855 basis points from the comparable as-filed period.
-33.35%→35.21%2 prior comparisons
Capital expenditure increased 66.4%
Capital expenditure changed +66.4% from the comparable as-filed period.
$1.3M→$2.2M3 prior comparisons
Research & development decreased 12.2%
Research & development changed -12.2% from the comparable as-filed period.
$113.0M→$99.2M2 prior comparisons
Working capital increased 12.2%
Working capital changed +12.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.6B→$1.8B4 prior comparisons
Capex / revenue moved 13 bp lower
Capex / revenue changed -13 basis points from the comparable as-filed period.
0.74%→0.61%2 prior comparisons
Cash & equivalents increased 3.2%
Cash & equivalents changed +3.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.0B→$1.0B4 prior comparisons
Current ratio decreased 6.2%
Current ratio changed -6.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
3.62→3.394 prior comparisons
Selling, general & administrative decreased 5.4%
Selling, general & administrative changed -5.4% from the comparable as-filed period.
$85.3M→$80.6M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.